Tuesday, July 1, 2025 7/1/2025

The role of neonatal ROS in cardiomyocyte maturation and injury response

Award Number: F31HL172609
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 01/01/2024
PERIOD OF PERFORMANCE END DATE: 12/31/2025

Group Awards By:

View Award Description

The role of neonatal ROS in cardiomyocyte maturation and injury response - ABSTRACT/PROJECT SUMMARY Ischemic heart disease presents a substantial burden of disease, partially due to cardiomyocytes’ low turnover rate. Neonatal mice exhibit a transient cardiac regenerative capacity and serve as a valuable model to study cardiac regeneration. Many in the field theorize that the driver of the regenerative to non-regenerative shift is the reactive oxygen species (ROS) increase that occurs after birth as pups shift from a low to a relatively high- oxygen environment. These ROS are thought to lead to DNA damage, resulting in cell cycle arrest. Although it is well established that high levels of ROS can drive pathology in a variety of tissue types, ROS serve as critical signaling molecules in a wide range of biological processes. One critical developmental process that occurs during the early neonatal period is the metabolic shift to fatty acid oxidation, which is a hallmark of cardiomyocyte maturation. The primary goal of this F31 research proposal is to determine the necessity of neonatal ROS increase in establishing oxidative tolerance in cardiomyocytes prior to ischemic injury (Aim 1) and in driving a metabolic shift to fatty acid oxidation that is characteristic of mature cardiomyocytes (Aim 2). This study includes an AAV9- delivered constitutively active Nrf2 as well as a high-dose antioxidant model to suppress ROS during the early neonatal period. Preliminary RNA sequencing data showed a decrease in genes associated with fatty acid oxidation in ROS-depleted cardiomyocytes compared to controls, suggesting that ROS are required for cardiomyocyte metabolic maturation. To further study the impact of abnormal metabolic shifts on cardiomyocyte regeneration, a Cd36 knockout and AAV9-delivered overexpression model will be utilized in combination with human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes (iCMs) studies to manipulate cell metabolism. The proposed study focuses on mitigation of neonatal development ROS to understand their role in cardiomyocyte maturation and establishing oxidative tolerance, in contrast to studies that have aimed to lower injury-related ROS. While cardiac pathology has mainly been attributed to oxidative stress, recent findings suggest that reductive stress may also have pathological implications. Elucidating the temporal regulation of ROS signaling and its influence on cardiomyocyte injury response and metabolism will help inform future therapeutics for the treatment of heart failure.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $51,974 )
2025	2025	THE MEDICAL UNIVERSITY OF SOUTH CAROLINA	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Cardiovascular Diseases Research	000	2	12/31/2024	NON-COMPETING CONTINUATION	$51,974
														Subtotal = $51,974

Issue Date FY: 2024 ( Subtotal = $51,974 )
2024	2024	THE MEDICAL UNIVERSITY OF SOUTH CAROLINA	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Cardiovascular Diseases Research	002	1	9/13/2024	NEW	$1,780
2024	2024	THE MEDICAL UNIVERSITY OF SOUTH CAROLINA	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Cardiovascular Diseases Research	001	1	12/30/2023	NEW	$0
2024	2024	THE MEDICAL UNIVERSITY OF SOUTH CAROLINA	179 ASHLEY AVE	CHARLESTON	SC	29425	CHARLESTON	USA	Cardiovascular Diseases Research	000	1	12/30/2023	NEW	$50,194
														Subtotal = $51,974

Grand Total All Awards = $103,948

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The role of neonatal ROS in cardiomyocyte maturation and injury response

Award Number: F31HL172609

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 01/01/2024

PERIOD OF PERFORMANCE END DATE: 12/31/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer